NOVARTIS AG : Novartis drug Zortress® is first in over a decade approved by ... 4-traders (press release) Basel, February 15, 2013 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. Zortress is the first ... FDA Nod For Novartis Drug To Avert Organ Failure In Liver Transplant US FDA okays Novartis drug to prevent liver transplant rejection |
